Glycaemic control and weight outcomes after adding or switching to biphasic insulin aspart 30/70 in people with type 2 diabetes mellitus previously treated with basal-bolus insulin in UK clinical practice

Diabetes Obes Metab. 2023 Dec;25(12):3841-3844. doi: 10.1111/dom.15278. Epub 2023 Sep 18.

¹ Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester General Hospital, Leicester, UK.
² NIHR Leicester Biomedical Research Centre, Leicester General Hospital, Leicester, UK.
³ Novo Nordisk, Søborg, Denmark.

No abstract available

Keywords: database research; glycaemic control; insulin therapy; observational study; real-world evidence; type 2 diabetes.

Publication types